SaifM. (2014) “MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients with Gemcitabine Refractory Metastatic Pancreatic Cancer”, JOP. Journal of the Pancreas, 15(3), pp. 278-279. doi: 10.6092/1590-8577/2507.